← Leaderboards
David Yue-Wei Lee
Mc Lean Hospital (Belmont, Ma)
$7,103,639
Attributed
$8,174,107
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$13,949,237 · 9
By mechanism
P01$7,617,220 · 3
R01$4,309,158 · 4
R42$1,800,182 · 1
R41$222,677 · 1
Top collaborators
- Lee-Yuan Liu-Chen5 shared
Most similar at Mc Lean Hospital (Belmont, Ma)
Same institution · by research overlap
- Scott E Lukas$22,952,121
Others in their field
Top investigators on “Pharmacotherapy”
- Carol Nesel · Westat$116,355,411
- Barbara Driver · Westat, Inc.$62,829,804
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Anastassios G Pittas · Tufts Medical Center$42,391,504
- Edward V Nunes · Columbia University Health Sciences$36,956,141
- Vance G Fowler · Duke University$30,735,128
Research focus
PharmacotherapyIn VitroIn VivoPharmacokineticsLeadReceptor BindingMetabolismClinical TrialsDrug Design /Synthesis /ProductionDrug Screening /EvaluationBiological FactorsChemical SynthesisCocaineLaboratory RatBehavioralAffinityAdverse EffectsLaboratoriesMotor ActivityDrug AddictionDrug AbuseCravingMediatingClinical Research
Grant awards (32)
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction$421,263
R01 · FY2016 · AT · contact PI
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction$415,870
R01 · FY2015 · AT · contact PI
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction$425,617
R01 · FY2014 · AT · contact PI
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction$420,961
R01 · FY2013 · AT · contact PI
Mechanism of Action of L THP as an Alternative Therapy for Cocaine Addiction$457,225
R01 · FY2012 · AT · contact PI
Pharmacology and Metabolism of Salvia divinorum$274,076
R01 · FY2010 · DA · contact PI
Pharmacology and Metabolism of Salvia divinorum$276,845
R01 · FY2009 · DA · contact PI
Alternative Therapies for Alcohol and Drug Abuse$1,107,705
P01 · FY2008 · AT · contact PI
Project 1 - Chemistry & In Vitro Studies of Chinese Herbal Remedies$393,141
P01 · FY2008 · AT · contact PI
Pharmacology and Metabolism of Salvia divinorum$276,845
R01 · FY2008 · DA · contact PI
Alternative Therapies for Alcohol and Drug Abuse$1,172,021
P01 · FY2007 · AT · contact PI
Project 1 - Chemistry & In Vitro Studies of Chinese Herbal Remedies$349,145
P01 · FY2007 · AT · contact PI
Pharmacology and Metabolism of Salvia divinorum$284,654
R01 · FY2007 · DA · contact PI
Alternative Therapies for Alcohol and Drug Abuse$1,142,933
P01 · FY2006 · AT · contact PI
Project 1 - Chemistry & In Vitro Studies of Chinese Herbal Remedies$333,237
P01 · FY2006 · AT · contact PI
Pharmacology and Metabolism of Salvia divinorum$217,181
R01 · FY2006 · DA · contact PI
Alternative Therapies for Alcohol and Drug Abuse$1,138,441
P01 · FY2005 · AT
Project 1 - Chemistry &In Vitro Studies of Chinese Herbal Remedies$323,531
P01 · FY2005 · AT
Alternative Therapies for Alcohol and Drug Abuse$1,214,030
P01 · FY2004 · AT
Project 1 - Chemistry &In Vitro Studies of Chinese Herbal Remedies$294,238
P01 · FY2004 · AT
Development of Standardized Milk Thistle Product$288,000
R42 · FY2004 · AT
Administrative Core$148,798
P01 · FY2004 · AT
Development of Standardized Milk Thistle Product$592,663
R42 · FY2003 · AT
Naturally Occurring Agent for Alcohol Liver Diseases$222,677
R41 · FY2003 · AA
Development of Standardized Milk Thistle Product$698,275
R42 · FY2002 · AT
NOVEL NEUROSTEROIDS FOR ALCOHOL-RELATED CONDITIONS$135,009
R01 · FY2002 · AA
NOVEL NEUROSTEROIDS FOR ALCOHOL-RELATED CONDITIONS$241,573
R01 · FY2001 · AA
Development of Standardized Milk Thistle Product$221,244
R42 · FY2001 · AT
SAR OF NOVEL TOPO I INHIBITOR AGAINST PROSTATE CANCER$112,075
R01 · FY2001 · CA
NOVEL NEUROSTEROIDS FOR ALCOHOL-RELATED CONDITIONS$39,998
R01 · FY2001 · AA
NOVEL NEUROSTEROIDS FOR ALCOHOL-RELATED CONDITIONS$232,412
R01 · FY2000 · AA
SAR OF NOVEL TOPO I INHIBITOR AGAINST PROSTATE CANCER$77,554
R01 · FY2000 · CA